APA (7th ed.) Citation

Zhang Q, Zhang J, Liu Z, Wang J, Wang F, Wang T, . . . Zhao Y. (2023). Recombinant Human Adenovirus Type 5 (H101) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Genomic Profiling Relating to Clinical Efficacy. Dove Medical Press.

Chicago Style (17th ed.) Citation

Zhang Q, Zhang J, Liu Z, Wang J, Wang F, Wang T, Shi F, Su J, and Zhao Y. Recombinant Human Adenovirus Type 5 (H101) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Genomic Profiling Relating to Clinical Efficacy. Dove Medical Press, 2023.

MLA (9th ed.) Citation

Zhang Q, et al. Recombinant Human Adenovirus Type 5 (H101) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Genomic Profiling Relating to Clinical Efficacy. Dove Medical Press, 2023.